FDA warns Ohio over execution drug; GSK gets permit for Memphis facility;

> The FDA has sent a letter to the Ohio Department of Rehabilitation and Correction warning that it must get FDA approval if it is thinking about importing a drug for executions. Story

> The FDA is warning providers not to use compounded drugs stored in Becton Dickinson ($BDX) 3 mL and 5 mL syringes because they are not approved as storage devices and drugs may be subpotent. Announcement

> GlaxoSmithKline ($GSK) has gotten a building permit for $2 million in modifications for a facility in Memphis, TN. Report